Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China.
Department of Rheumatology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China.
J Immunol Res. 2017;2017:9786972. doi: 10.1155/2017/9786972. Epub 2017 Aug 16.
A derivative formula, DGBX, which is composed of three herbs (, , and Franch), is derived from a famous Chinese herbal formula, Danggui Buxue Tang (DBT) ( and ). We aimed to investigate the effects of DGBX on the regulation of the balance between proliferation and apoptosis of hematopoietic stem cells (HSCs) due to the aberrant immune response in a mouse model of aplastic anemia (AA). Cyclosporine (CsA), an immunosuppressor, was used as the positive control. Our results indicated that DGBX could downregulate the production of IFN in bone marrow cells by interfering with the binding between SLAM and SAP and the expressions of Fyn and T-bet. This herbal formula can also inhibit the activation of Fas-mediated apoptosis, interferon regulatory factor-1-induced JAK/Stat, and eukaryotic initiation factor 2 signaling pathways and thereby induce proliferation and attenuate apoptosis of HSCs. In conclusion, DGBX can relieve the immune-mediated destruction of HSCs, repair hematopoietic failure, and recover the hematopoietic function of HSCs in hematogenesis. Therefore, DGBX can be used in traditional medicine against AA as a complementary and alternative immunosuppressive therapeutic formula.
一种衍生配方 DGBX,由三种草药(、和)组成,源自一种著名的中药配方当归补血汤(DBT)(和)。我们旨在研究 DGBX 对再生障碍性贫血(AA)小鼠模型中由于异常免疫反应导致的造血干细胞(HSCs)增殖和凋亡平衡调节的影响。环孢素(CsA)作为免疫抑制剂被用作阳性对照。我们的结果表明,DGBX 可以通过干扰 SLAM 和 SAP 的结合以及 Fyn 和 T-bet 的表达来下调骨髓细胞中 IFN 的产生。这种草药配方还可以抑制 Fas 介导的凋亡、干扰素调节因子-1 诱导的 JAK/Stat 和真核起始因子 2 信号通路的激活,从而诱导 HSCs 的增殖和减轻凋亡。总之,DGBX 可以缓解免疫介导的 HSCs 破坏,修复造血衰竭,并恢复 HSCs 在造血中的功能。因此,DGBX 可以在传统医学中用作治疗 AA 的补充和替代免疫抑制治疗配方。